Publicaciones en las que colabora con Angel Arenal Maíz (11)

2021

  1. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies

    Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 296-302

2020

  1. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy

    ESC Heart Failure, Vol. 7, Núm. 1, pp. 279-283

  2. Sex differences in implantable cardiac defibrillator therapy according to arrhythmia detection times

    Heart, Vol. 106, Núm. 7, pp. 520-526

2019

  1. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices

    Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275

  2. Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030

  3. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis

    International Journal of Cardiology, Vol. 274, pp. 163-169

2017

  1. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy

    Europace, Vol. 19, Núm. 11, pp. 1818-1825

  2. Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial

    JACC: Clinical Electrophysiology, Vol. 3, Núm. 11, pp. 1275-1282

2016

  1. Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: Data from the ADVANCE III trial

    Europace, Vol. 18, Núm. 11, pp. 1719-1725

2014

  1. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: Data from the avoid delivering therapies for nonsustained arrhythmias in ICD patients III (ADVANCE III) trial

    Circulation, Vol. 130, Núm. 4, pp. 308-314

2013

  1. Novedades en alteraciones del ritmo cardiaco: electrofisiología cardiaca, arritmias y estimulación cardiaca

    Revista Espanola de Cardiologia, Vol. 66, Núm. 2, pp. 116-123